1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Suarez-Garcia, Ines, Alejos, Belen, Moreno, Cristina, De Miguel, Rosa, Aldamiz-Echevarria, Teresa, Garcia-Fraile, Lucio Jesus, Pitarch, Maria Tasias, Martinez, Desiree Perez, Antela, Antonio, Moreno, Santiago, Jarrin, Inma.

    Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort

    HIV MEDICINE . : .

    [doi:10.1111/hiv.70183]

  • de Morales, Alejandro G. Garcia-Ruiz, Vivancos, Maria Jesus, Romero-Hernandez, Beatriz, Rial-Crestelo, David, de las Revillas, Francisco Arnaiz, Sanchez-Villegas, Jorge, Alonso, Marta Montero, Sanchez, Maria De La Villa Lopez, Valls, Maria Remedios Aleman, Moreno, Santiago, Martinez-Sanz, Javier, Perez-Elias, Maria Jesus, CoRIS.

    Low-effort HIV training in Spanish primary care: Long-term impact on testing and diagnosis

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 43(10): 645-651.

    [doi:10.1016/j.eimc.2025.06.016]

  • García-Ruiz de Morales AG, Vivancos MJ, Romero-Hernández B, Rial-Crestelo D, Arnaiz de Las Revillas F, Sanchez-Villegas J, Montero Alonso M, López Sánchez MV, Alemán Valls MR, Moreno S, Martínez-Sanz J, Pérez-Elías MJ.

    Low-effort HIV training in Spanish primary care: Long-term impact on testing and diagnosis.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . 43(10): 645-651.

    [doi:10.1016/j.eimce.2025.06.015]

  • Martínez-Sanz J, García-Ruiz de Morales AG, Macías J, Rivero A, Blanco Arévalo JL, Ortiz de Barrón XC, Calzado Isbert S, Novella Mena M, Sánchez-Conde M, Moreno S.

    Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023

    CLINICAL INFECTIOUS DISEASES . : .

    [doi:10.1093/cid/ciaf622]

  • Ryan P, Berenguer J, Ramos-Ruperto L, Vera M, Martín-Carbonero L, Pérez-Latorre L, De Los Santos I, Pinto A, Vivancos MJ, Orviz E, Álvarez B, Sanz J, Ruiz-Seco P, Torres R, Brazal B, De Miguel M, López-Centeno B, Jarrín I, Resino S, Bellón JM, González-García J.

    Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022-2024)

    Open forum infectious diseases . 12(12): .

    [doi:10.1093/ofid/ofaf678]

  • Bravo-Queipo-de-Llano B, Prieto Tato LM, Noguera-Julian A, Escosa-García L, Frick MA, Bustillo M, Ramos JT, Gavilán Martín C, Collado-Hernández P, Navarro Gómez M, Serrano-Villar S, Sainz Costa T.

    Weight Gain Among Children and Adolescents on Dolutegravir in Spain

    Journal of the Pediatric Infectious Diseases Society . 14(12): .

    [doi:10.1093/jpids/piaf110]

  • Casado JL, Blanco JL, Izuzquiza I, Moreno A, Vizcarra P, Vallejo A.

    From TRIO to one: simplification to bictegravir/emtricitabine/tenofovir alafenamide in highly treatment-experienced people living with MDR HIV

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 80(12): 3242-3247.

    [doi:10.1093/jac/dkaf357]

  • Buzón-Martín L, Montes ML, Pedrero R, Galindo MJ, Santacreu-Guerrero M, Alemán MR, Torralba M, Díaz de Santiago A, Fanjul F, Rodríguez A, Cabello A, Crusells MJ, Navarro MDC, Aguilera M, Hidalgo-Tenorio C, Morano-Amado LE, Vinuesa D, De Andres C, Bernal-Morell E, Martínez-Álvarez RM, Cabello-Clotet N, Tiraboschi J, Montero MDC, Vivancos-Gallego MJ, Díez C, Calderón R, De Zárraga MA, Gisbert L, Romero-Palacios A, Cabo R, Soler JF, Sepúlveda MA, Sánchez-Guirao AJ, Escrich C, Arnaiz De Las Revillas F, Ferreira E, Valentín B, Lérida A, Llenas-García J, Gómez A, Losa JE, Alonso B, Sanz J, Masiá M, Pernas H, Corte JJ, Garcinuño MÁ, Gainzarain JC, Estébanez M, García-Navarro MDM, Barragán P, Ramos N, Clavero M, Millán M, Del Álamo M, Egido M, De La Calle B, Ferrero OL, Troya J.

    A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 80(12): 3438-3451.

    [doi:10.1093/jac/dkaf389]

  • Espinosa-Del-Barrio L, Gómez G de la Pedrosa E, Álvarez-Díaz N, Guzmán Martínez J, Corbacho Loarte MD, Escudero Sánchez R, Martín-Dávila P, Fortún Abete J, Cobo Reinoso J, Pintado García V, Gioia F.

    Aspergillus Endocarditis in Native Valves in Non-Traditional Hosts: A Systematic Review of a Case in a Patient with CREST Syndrome and Advanced Liver Cirrhosis.

    JOURNAL OF FUNGI . 11(12): .

    [doi:10.3390/jof11120836]

  • Escudero-Sanchez R, Morata L, Buzón L, de la Villa S, Rico A, Nuñez Orantos MJ, Guio Carrion L, Tasias Pitarch M, Del Pozo JL, Barbero JM, Gómez-Junyent J, García Pais MJ, Bachiller Luque P, Martínez Marcos FJ, Cobo J, Geio Spanish Group For Osteoarticular Infections.

    Dalbavancin as Suppressive Therapy for Implant-Associated Osteoarticular Infections

    ANTIBIOTICS-BASEL . 14(11): .

    [doi:10.3390/antibiotics14111171]

  • Pascucci D, Nicolàs A, Taha A, Lazarus JV, Di Pumpo M, Tricomi V, Di Berardino F, La Vecchia C, Perez-Molina JA, Colucci G, Picchio CA, Pezzullo AM, Boccia S.

    Monitoring and evaluation of community interventions for viral hepatitis among migrants and refugees: a Delphi-based study

    Journal of Global Health . 15: 4335-4335.

    [doi:10.7189/jogh.15.04335]

  • Isla D, Zugazagoitia J, Arriola E, García-Campelo R, Martí Blanco C, Diz-Taín MP, López-Brea M, Moreno-Vega AL, León-Mateos L, Oramás J, Gutiérrez-Calderón V, Majem M, Sánchez-Hernández A, Aguado C, Alvarez-Cabellos R, Massutí B, Moreno A, Fírvida-Pérez JL, Valdivia J, González-Cordero M, Zafra-Poves M, Dómine M, Garcia-Navalon FJ, Villanueva N, Provencio M, Juan-Vidal O, Rivas-Corredor C, Olmedo García ME, Palmero R, López-Castro R, Carcereny E, Lechuga JL, Domínguez M, Callejo Á, Paz-Ares L.

    Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial

    Lung Cancer . 209: 108763-108763.

    [doi:10.1016/j.lungcan.2025.108763]

  • Velasco M, Flores-Chávez MD, Llenas-García J, García Rodríguez M, García Vázquez E, López-Medrano F, Len O, Esperalba Esquerra J, Martínez Pérez Á, Díaz-Menéndez M, Moure García Z, Pérez Ayala A, Rodríguez Guardado A, Albasanz Puig A, Alguacil M, Álvarez-Martínez MJ, Arsuaga Vicente M, Belhassen Garcia M, Buitrago MJ, Calabuig E, de la Calle F, Dopico E, Fernández-Ruiz M, Gudiol C, Herrero-Martínez JM, Lozano Serrano AB, Martin O, Martín-Dávila P, de Miguel R, Muelas Fernández M, Navarro Beltrá M, Norman FF, Palacios Gutiérrez JJ, Pérez-Jacoiste A, Rodríguez-Sevilla G, Rodríguez Zúñiga D, Salvador F, Sánchez Montalvá A, Seral C, Vázquez González A, Wikman Jorgensen PE, Sulleiro Igual E.

    Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC: GEPI, GeSIDA, GESITRA-IC, GEIRAS) on screening for imported infectious diseases in immunocompromised patients.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . 43(9): 611-615.

    [doi:10.1016/j.eimce.2025.07.005]

  • Díaz-García C, Serrano-Villar S, G García-Ruiz de Morales A, Güerri-Fernández R, Pérez-Somarriba J, Sánchez Palomino S, Suárez-García I, Hernández Gutiérrez C, Dalmau Juanola D, Moreno S, Moreno E, Martínez-Sanz J.

    Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment

    Open forum infectious diseases . 12(11): .

    [doi:10.1093/ofid/ofaf626]

  • Gayoso Cantero D, Fernández-González P, Chamorro-Tojeiro S, Quereda C, Tato M, Berna-Rico E, Naharro-Rodríguez J, Perez-Molina JA.

    Clinical, therapeutic, and stigma-related challenges in leprosy and the emerging role of apremilast in managing leprosy reactions

    TRAVEL MEDICINE AND INFECTIOUS DISEASE . 68: 102918-102918.

    [doi:10.1016/j.tmaid.2025.102918]

  • Behrens GMN, Assoumou L, De Wit S, MacDonald R, de Castro N, Rokx C, Middleditch H, Johnson M, Casado JL, Arribas JR, Blanco JR, Fletcher C, Eteve-Pitsaer C, Baldé A, Pozniak A, Martinez E.

    Morbidity and risk factors of COVID-19 in people with HIV-1 in Europe: A combined observational cohort and nested case-control study

    HIV MEDICINE . 26(11): 1657-1672.

    [doi:10.1111/hiv.70094]

  • Gayoso Cantero D, Corbacho Loarte MD, Monge Maillo B.

    Diagnostic delay in Strongyloides stercoralis infections.

    MEDICINA CLINICA . 165(5): 107123-107123.

    [doi:10.1016/j.medcli.2025.107123]

  • Maertens JA, Thompson GR 3rd, Spec A, Donovan FM, Hammond SP, Bruns AHW, Rahav G, Shoham S, Johnson R, Rijnders B, Schaenman J, Hoenigl M, Morrissey CO, Mehta SR, Heath CH, Koehler P, Paterson DL, Slavin MA, Fortún J, Nguyen MH, Patterson TF, Uspenskaya O, Van de Veerdonk FL, Verweij PE, Aoun M, Georgala A, Alexander BD, Chayakulkeeree M, Mehra V, Miceli MH, Sikka MK, Solé A, Walsh TJ, Aguado JM, Holland SM, Moussa M, Rautemaa-Richardson R, Bazaz R, Schwartz S, Walsh SR, Plate M, Yehudai-Ofir D, Brüggemann RJ, Cornely OA, Ostrosky-Zeichner L, Vazquez JA, White PL, Cornelissen K, Ross GG, Fitton L, Dane A, Zinzi D, Rex JH, Chen SC.

    Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.

    The Lancet. Infectious diseases . 25(11): 1177-1188. Nº de citas: 20

    [doi:10.1016/S1473-3099(25)00224-5]